References

  1. Schmunis G, Zicker F, Cruz JR, Cuchi P. Safety of blood supply for infectious disease in Latin American countries, 1994-1997. Am J Trop Med Hyg. 2001; 65(6): 924-930. PubMed | Google Scholar

  2. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med. 1996; 334(26): 1685-1690. PubMed | Google Scholar

  3. Pillonel J, Laperche S, Saura C, Desenclos JC, Courouce AM. The transfusion-transmissible agents working group of the French Society of Blood Transfusion, Trends in residual risk of transfusion-transmitted viral infections in France between 1992 and 2000. Transfusion. 2002; 42(8): 980-988. PubMed| Google Scholar

  4. UNAIDS. Blood safety and HIV: Technical update, Joint United Nations Programme on HIV/AIDS, Geneva, Switzerland. UNAIDS. October 1997; 2-4. Google Scholar

  5. Sarkodie F, Adarkwa M, Adu-Sarkodie Y, Candotti D, Acheampong JW, Allain JP. Screening for viral markers in volunteer and replacement blood donors in West Africa. Vox Sang. 2001; 80(3): 142-147. PubMed | Google Scholar

  6. Mbanya DN, Takam D and Ndumbey PM. Serological findings amongst first-time blood donors in Yaounde, Cameroon: is safe donation a reality or a myth. Transfus Med. 2003; 13(5): 267-273. Google Scholar

  7. Tayou Tagny C, Diarra A, Yahaya R, Hakizimana M, Nguessan A, Mbensa G, Nébié Y, Dahourou H, Mbanya D, Shiboski C, Murphy E and Lefrère JJ. Characteristics of blood donors and donated blood in sub-Saharan Francophone Africa. Transfusion. 2009; 49(8): 1592-1599. PubMed | Google Scholar

  8. Manns A, Hisada M, La Grenade L. Human T-lymphotropic virus type I infection. Lancet. 1999; 353(9168): 1951-1958. PubMed | Google Scholar

  9. Murphy EL, Glynn SA, Fridey J, Sacher RA, Smith JW, Wright DJ, Newman B, Gibble JW, Ameti DI, Nass CC, Schreiber GB, Nemo GJ. Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I and II-infected blood donors, Retrovirus Epidemiology Donor Study (REDS) Study Group. J Infect. 1997; 176(6): 1468-1475. PubMed | Google Scholar

  10. Murphy EL, Wang B, Sacher RA, Fridey J, Smith JW, Nass CC, Newman B, Ownby HE, Garratty G, Hutching ST, Schreiber GB. Respiratory and urinary tract infections, arthritis and asthma associated with HTLV-I and HTLV-II infection. Emerg Infect. 2004; 10(1): 109-116. PubMed

  11. Roucoux DF, Murphy EL. The epidemiology and disease outcomes of human T-lymphotropic virus type II. AIDS Rev. 2004; 6(3): 144-154. PubMed | Google Scholar

  12. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005; 24(39): 6058-6068. PubMed | Google Scholar

  13. Hunsmann G, Bayer H, Schneider J, Schmitz H, Kern P, Dietrich M, Buttner DW, Goudeau AM Kuekarni G and Fleming AF. Antibodies to ATLV/HTLV-1 in Africa. Med Microbiol immunol. 1984; 173(3): 167-170. PubMed | Google Scholar

  14. Kiire CF. The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa. Gut. 1996; 38(Suppl 2): S5-S12. PubMed | Google Scholar

  15. Bihl F, Castelli D, Marincola F, Dodd YR and Brander C. Transfusion-transmitted infections. Journal of Transl Med. 2007; 5: 25. PubMed | Google Scholar

  16. Bhattacharya P, Chandra PK, Datta S, Banerjee A, Chakraborty S, Rajendran K, Basu SK, Bhattacharya SK, Chakravarty R. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol. 2007; 13(27): 3730-3733. PubMed

  17. Dourado I, Alcantara LCJ, Barreto ML, da Gloria TM, Galvão-Castro B. HTLV-I in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics. J Acquir Immune Defic Syndr. 2003; 34(5): 527-31. PubMed | Google Scholar

  18. Santos RF, Conceição GC, Martins MS, Kraychete A, Penalva MA, Carvalho EM, Lopes AA, Rocha PN. Prevalence and risk factors for Human T-Lymphotropic Virus Type 1 (HTLV-1) among maintenance hemodialysis patients. BMC Nephrol. 2017; 18(1): 64. PubMed | Google Scholar

  19. Blattner WA. T-lymphotropic viruses and diseases of long latency. Ann Intern Med. 1989; 111(1): 4-6. PubMed | Google Scholar